# Comparison of Insulin Degludec With Insulin Glargine in Subjects With Type 1 Diabetes Mellitus

> **NCT01868529** · PHASE1 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 63 (actual)

## Conditions studied

- Diabetes
- Diabetes Mellitus, Type 1

## Interventions

- **DRUG:** insulin degludec
- **DRUG:** insulin glargine

## Key facts

- **NCT ID:** NCT01868529
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2008-06
- **Final completion:** 2008-06
- **Target enrollment:** 63 (ACTUAL)
- **Last updated:** 2015-09-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01868529

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01868529, "Comparison of Insulin Degludec With Insulin Glargine in Subjects With Type 1 Diabetes Mellitus". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01868529. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*